| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 89-93, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
TJ Montine, V Amarnath, ME Martin, WJ Strittmatter and DG Graham
Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.
Lipid peroxidation increases with age in brain and is elevated further in Alzheimer's disease. E-4-hydroxy-2-nonenal and malondialdehyde are products of lipid peroxidation that can adduct and cross-link protein. Neurofibrillary tangles, a feature of Alzheimer's disease composed mostly of tau protein, contain cross-linked and ubiquitin-conjugated protein. In P19 neuroglial cultures, E-4-hydroxy-2-nonenal was a potent cytotoxin that cross-linked cytoskeletal proteins, including tau into high molecular weight species that were conjugated with ubiquitin. Malondialdehyde formed monoadducts with cell protein but did not cross- link and was not cytotoxic. A non-crosslinking analogue of E-4-hydroxy- 2-nonenal was not cytotoxic. E-4-Hydroxy-2-nonenal may contribute to neurodegeneration and neurofibrillary tangle formation in Alzheimer's disease.
This article has been cited by other articles:
![]() |
S. N. A. Hussain, G. Matar, E. Barreiro, M. Florian, M. Divangahi, and T. Vassilakopoulos Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L996 - L1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Burcham and S. M. Pyke Hydralazine Inhibits Rapid Acrolein-Induced Protein Oligomerization: Role of Aldehyde Scavenging and Adduct Trapping in Cross-Link Blocking and Cytoprotection Mol. Pharmacol., March 1, 2006; 69(3): 1056 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Moreira, K. Honda, X. Zhu, A. Nunomura, G. Casadesus, M. A. Smith, and G. Perry Brain and brawn: Parallels in oxidative strength Neurology, January 24, 2006; 66(1_suppl_1): S97 - S101. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. MOREIRA, M. A. SMITH, X. ZHU, A. NUNOMURA, R. J. CASTELLANI, and G. PERRY Oxidative Stress and Neurodegeneration Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 545 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sowell, B. Frei, and J. F. Stevens Vitamin C conjugates of genotoxic lipid peroxidation products: Structural characterization and detection in human plasma PNAS, December 28, 2004; 101(52): 17964 - 17969. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schutt, M. Bergmann, F. G. Holz, and J. Kopitz Proteins Modified by Malondialdehyde, 4-Hydroxynonenal, or Advanced Glycation End Products in Lipofuscin of Human Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3663 - 3668. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wataya, A. Nunomura, M. A. Smith, S. L. Siedlak, P. L. R. Harris, S. Shimohama, L. I. Szweda, M. A. Kaminski, J. Avila, D. L. Price, et al. High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal J. Biol. Chem., February 8, 2002; 277(7): 4644 - 4648. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R. L. Russell, C. S. Atwood, A. B. Johnson, Y. Kress, H. V. Vinters, M. Tabaton, et al. Mitochondrial Abnormalities in Alzheimer's Disease J. Neurosci., May 1, 2001; 21(9): 3017 - 3023. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. ROBERTS II, R. G. SALOMON, J. D. MORROW, and C. J. BRAME New developments in the isoprostane pathway: identification of novel highly reactive {gamma}-ketoaldehydes (isolevuglandins) and characterization of their protein adducts FASEB J, July 1, 1999; 13(10): 1157 - 1168. [Abstract] [Full Text] |
||||
![]() |
A. Nunomura, G. Perry, M. A. Pappolla, R. Wade, K. Hirai, S. Chiba, and M. A. Smith RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer's Disease J. Neurosci., March 15, 1999; 19(6): 1959 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mark, Z. Pang, J. W. Geddes, K. Uchida, and M. P. Mattson Amyloid beta -Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation J. Neurosci., February 1, 1997; 17(3): 1046 - 1054. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |